The Nimbus device: designed to respond to tough clots
How do you choose the right device to deal with the challenges of tough clots?
If you followed the Cerenovus sponsored “tough clots” symposium during LINNC Paris 2022 you would know – but even if you didn’t – Drs Pasquale Mordasini and Mohamed Aggour review the key points here underlining why the innovative Nimbus device could be your choice.
Advances in stroke treatment have been phenomenal, but challenges remain in fully recanalizing arteries – what are the complications? In which situation do failures occur? Are there specific types of occlusion patterns? Anterior or posterior circulation? Anatomy? And what about the clot itself?
How do the specificities of the Nimbus architecture – with its separate spiral and barrel sections – respond best to removing tough and challenging clots? Is it only a rescue device…or can Nimbus be used as a first pass choice? Join this discussion and find out…
Going Further - Cerenovus proposes solutions to facilitate your interventions